Oppenheimer raised the firm’s price target on Pacs Group (PACS) to $42 from $40 and keeps an Outperform rating on the shares following the company’s Q4 results and 10-K. Following its internal investigation and related reporting delays, Pacs Group is looking to gain operational momentum in 2026, the firm notes.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACS: